MRC Epidemiology Unit - Publications Database

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis.

Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, Smith M, Archer L, Levis B, Payne RA, Riley RD, Roberts N, Snell KIE, Lay-Flurrie S, Usher-Smith J, Stevens R, Hobbs FDR, McManus RJ, Sheppard JP, STRATIFY investigators STRATIFY investigators

BMJ (Clinical research ed.). Feb 2021

(DOI : 10.1136/bmj.n189)

The Use of Primary Care Big Data in Understanding the Pharmacoepidemiology of COVID-19: A Consensus Statement From the COVID-19 Primary Care Database Consortium.

Dambha-Miller H, Griffin SJ, Young D, Watkinson P, Tan PS, Clift AK, Payne RA, Coupland C, Hopewell JC, Mant J, Martin RM, Hippisley-Cox J

Annals of family medicine. May 2020

(DOI : 10.1370/afm.2658)

Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial.

Silarova B, Sharp SJ, Usher-Smith JA, Lucas J, Payne RA, Shefer G, Moore C, Girling C, Lawrence K, Tolkien Z, Walker M, Butterworth A, Di Angelantonio E, Danesh J, Griffin SJ

Heart (British Cardiac Society). Sep 2018

(DOI : 10.1136/heartjnl-2018-314211)

Factors Associated With Engagement With a Web-Based Lifestyle Intervention Following Provision of Coronary Heart Disease Risk: Mixed Methods Study.

Usher-Smith JA, Winther LR, Shefer G, Silarova B, Payne RA, Griffin SJ

Journal of medical Internet research. Mar 2017

(DOI : 10.2196/jmir.7697)

Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.

Silarova B, Lucas J, Butterworth AS, Di Angelantonio E, Girling C, Lawrence K, Mackintosh S, Moore C, Payne RA, Sharp SJ, Shefer G, Tolkien Z, Usher-Smith J, Walker M, Danesh J, Griffin SJ

BMC Public Health. Jul 2015

(DOI : 10.1186/s12889-015-2192-5)